Pneumatosis intestinalis is a rare but known potential complication of treatment with cetuximab. Here we present two cases of pneumatosis intestinalis occurring in patients who were receiving cetuximab as treatment for advanced head and neck cancer. In both cases, cetuximab was discontinued after discovery of the pneumatosis intestinalis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532904 | PMC |
http://dx.doi.org/10.1155/2015/214236 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!